Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Capital Leases: 2021-2024

Historic Capital Leases for Nutex Health (NUTX) over the last 4 years, with FY2024 value amounting to $259.5 million.

  • Nutex Health's Capital Leases rose 1210.04% to $270.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.1 million, marking a year-over-year increase of 1210.04%. This contributed to the annual value of $259.5 million for FY2024, which is 2131.64% up from last year.
  • Per Nutex Health's latest filing, its Capital Leases stood at $259.5 million for FY2024, which was up 2131.64% from $213.9 million recorded in FY2023.
  • In the past 5 years, Nutex Health's Capital Leases registered a high of $259.5 million during FY2024, and its lowest value of $65.7 million during FY2021.
  • Its 4-year average for Capital Leases is $185.7 million, with a median of $208.8 million in 2022.
  • In the last 5 years, Nutex Health's Capital Leases skyrocketed by 20975.61% in 2022 and then surged by 504.2% in 2023.
  • Nutex Health's Capital Leases (Annual) stood at $65.7 million in 2021, then soared by 209.76% to $203.6 million in 2022, then increased by 5.04% to $213.9 million in 2023, then increased by 21.32% to $259.5 million in 2024.
  • Its Capital Leases was $259.5 million in FY2024, compared to $213.9 million in FY2023 and $203.6 million in FY2022.